Indication of thrombolysis for middle cerebral artery occlusion using MR diffusion - weighted image

T Inagaki1, K Saito, T Okuyama

  • 1Kushiro Neurosurgical Hospital; Hokkaido, Japan.

Insights

Diffusion-weighted MRI (DWI) helps identify stroke patients who can benefit from thrombolytic therapy. DWI findings, combined with cerebral blood flow (CBF) SPECT scans, aid in selecting patients for reperfusion and improving outcomes.

Area of Science:

  • Neurology
  • Radiology
  • Cardiovascular Medicine

Background:

  • Acute occlusive cerebrovascular disease requires timely intervention.
  • Thrombolytic therapy offers a potential treatment for acute stroke.
  • Accurate patient selection is crucial for successful thrombolytic therapy.

Purpose of the Study:

  • To evaluate the utility of diffusion-weighted MRI (DWI) in guiding emergent thrombolytic revascularization therapy.
  • To correlate DWI findings with cerebral blood flow (CBF) measurements.
  • To identify indicators for selecting patients eligible for thrombolytic treatment.

Main Methods:

  • Diffusion-weighted MRI (DWI) was performed on 29 patients with acute middle cerebral artery occlusion.
  • Patients were assessed within six hours of symptom onset.
  • DWI findings were correlated with SPECT-measured CBF and classified into four types based on lesion extent.

Main Results:

  • Nine patients received thrombolytic therapy, with seven achieving revascularization and good outcomes.
  • DWI high-intensity areas indicated established infarction, irrespective of treatment.
  • Thrombolytic therapy successfully salvaged low CBF areas on SPECT, improving clinical symptoms.

Conclusions:

  • The "ischemic penumbra" was defined as areas of low CBF without DWI high intensity.
  • DWI classification is a valuable tool for determining thrombolytic therapy indications.
  • This approach can optimize treatment selection for acute stroke patients.

Related Concept Videos